| William Edward Lloyd, MD | |
|
113 Holland Avenue, Albany, NY 12208 | |
| (518) 626-6597 | |
| (518) 626-6606 |
| Full Name | William Edward Lloyd |
|---|---|
| Gender | Male |
| Speciality | Surgery - Vascular Surgery |
| Location | 113 Holland Avenue, Albany, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639125388 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 185683 (New York) | Secondary |
| 2086S0129X | Surgery - Vascular Surgery | 185683 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| William Edward Lloyd, MD 113 Holland Avenue, Albany, NY 12208 Ph: (518) 626-6597 | William Edward Lloyd, MD 113 Holland Avenue, Albany, NY 12208 Ph: (518) 626-6597 |
News Archive
Fero Industries, Inc. is pleased to announce that it has contracted PNP Pharmaceuticals Inc. as the exclusive global manufacturer of Sucanon®, an oral treatment for type-2 diabetes.
For many months, the world has witnessed the Ebola virus spread and claim more than 4,400 lives in West African countries. On Oct. 8, the first confirmed adult Ebola patient identified in the United States died. The constant news coverage has heightened concern among parents who fear their children will become infected. Jill Hoffman, MD, a pediatric Infectious diseases specialist at Children's Hospital Los Angeles, discusses the facts about Ebola, how parents can help their children prevent further outbreak by teaching them good hygiene, and how CHLA is prepared to identify and treat suspected Ebola patients.
Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for heart failure patients, announced the closing of its previously announced underwritten public offering of 6,500,000 units of its securities consisting of an aggregate of 6,500,000 shares of common stock and warrants to purchase an aggregate of 1,950,000 shares of common stock.
Esperion Therapeutics, a privately held biopharmaceutical company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that TransGenRx, a global leader in transgenic technology, will produce protein-based therapeutics to be used in the company's research efforts targeting HDL therapies for the treatment of cardio-metabolic disease.
› Verified 5 days ago
Dr. Todd Beyer, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 47 New Scotland Ave, Albany, NY 12208 Phone: 518-262-5623 Fax: 518-262-5560 | |
Dr. Carl Rosati, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 47 New Scotland Ave, Albany, NY 12208 Phone: 518-262-5623 Fax: 518-262-5560 | |
Adriana Laser, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 391 Myrtle Ave Ste 5, Albany, NY 12208 Phone: 518-262-5640 | |
Dr. John B Waldman, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 47 New Scotland Ave, Albany, NY 12208 Phone: 518-262-5088 Fax: 518-262-5400 | |
Dr. Andrew L Isenberg, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 319 S Manning Blvd Ste 304, Albany, NY 12208 Phone: 518-525-5206 | |
Dr. Edward Choongho Lee, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 47 New Scotland Ave, Albany, NY 12208 Phone: 518-262-5623 Fax: 518-262-5560 | |
Dr. Elizabeth Robison, MD Surgery Medicare: Medicare Enrolled Practice Location: 113 Holland Ave, Mail Code 112, Albany, NY 12208 Phone: 518-626-6588 Fax: 518-626-6606 |